GlassScriptPhysician profile
Casey Connors
NPI 1154813061
$4,767.65
in general payments reported to CMS, 2019-2025
10 companies · $1,977 in 2025
The $1,977 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,415 · 2024: $1,376 · 2025: $1,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,424 · Food and Beverage: $2,133 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,424.49 |
| Food and Beverage | $2,133.16 |
| Education | $210.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,894.36 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Medtronic, INC. | $961.95 | 2023 | Plasmablade(Tm) |
| Elucent Medical | $483.21 | 2024 | |
| Hologic INC | $379.08 | 2024 | Biozorb, Localizer |
| Stryker Corporation | $248.90 | 2024-2025 | Spy-Phi System, Molli |
| Davol INC. | $242.60 | 2023 | Arista Ah Flexitip |
| Leica Microsystems INC. | $210.00 | 2023 | |
| Endomagnetics LTD | $135.91 | 2024 | Magseed, Magtrace |
| Dilon Technologies, INC. | $122.05 | 2025 | Hemoblast Bellows |
| Merck Sharp & Dohme LLC | $89.59 | 2024 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Connors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.